Hybribio Biotech to host investor briefing on 2025 interim performance

Guangdong Hybribio Biotech Co., Ltd. announced its participation in the "Toward New Quality and Value Leadership - 2025 Guangdong Jurisdiction Investor Collective Reception Day and Interim Performance Briefing for Listed Companies" event. This event is jointly organized by the Guangdong Securities Regulatory Bureau and the Guangdong Association of Listed Companies.

The investor reception will be conducted online via the "Panorama Roadshow" website, the "Panorama Finance" WeChat official account, or the Panorama Roadshow APP. The interactive session is scheduled for Friday, September 19, 2025, from 3:30 PM to 5:00 PM.

During the event, Hybribio Biotech's management will be online to address investors' concerns regarding its 2025 semi-annual performance, corporate governance, development strategies, operational status, and sustainable development. The company encourages a wide range of investors to participate in this interactive communication.